Climb Bio, Inc. (CLYM)
10.28
-0.59
(-5.43%)
USD |
NASDAQ |
Nov 13, 11:23
Climb Bio Net Income (Annual) : -59.85M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -59.85M |
| December 31, 2024 | -73.90M |
| December 31, 2023 | -35.12M |
| December 31, 2022 | -45.24M |
| Date | Value |
|---|---|
| December 31, 2021 | -47.48M |
| December 31, 2020 | -20.67M |
| December 31, 2019 | -6.547M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Korsana Biosciences, Inc. | -3.528M |
| Cullinan Therapeutics, Inc. | -219.88M |
| Q32 Bio, Inc. | 29.82M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |